These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28587493)

  • 1. A randomized controlled trial of a new treatment for labor dystocia.
    Wiberg-Itzel E; Wray S; Åkerud H
    J Matern Fetal Neonatal Med; 2018 Sep; 31(17):2237-2244. PubMed ID: 28587493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate in Amniotic Fluid: Predictor of Labor Outcome in Oxytocin-Augmented Primiparas' Deliveries.
    Wiberg-Itzel E; Pembe AB; Järnbert-Pettersson H; Norman M; Wihlbäck AC; Hoesli I; Todesco Bernasconi M; Azria E; Åkerud H; Darj E
    PLoS One; 2016; 11(10):e0161546. PubMed ID: 27783611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amniotic fluid lactate (AFL): a new predictor of labor outcome in dystocic deliveries.
    Wiberg-Itzel E
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7306-7311. PubMed ID: 34758684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated amniotic fluid lactate predicts labor disorders and cesarean delivery in nulliparous women at term.
    Murphy M; Butler M; Coughlan B; Brennan D; O'Herlihy C; Robson M
    Am J Obstet Gynecol; 2015 Nov; 213(5):673.e1-8. PubMed ID: 26116871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-medicalization of birth by reducing the use of oxytocin for augmentation among first-time mothers - a prospective intervention study.
    Gaudernack LC; Frøslie KF; Michelsen TM; Voldner N; Lukasse M
    BMC Pregnancy Childbirth; 2018 Mar; 18(1):76. PubMed ID: 29587658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index and labor outcome associated with the level of amniotic fluid lactate.
    Karlsson S; Patavoukas E; Sterpu I; Wallstrom T; Wiberg-Itzel E
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8521-8529. PubMed ID: 34696678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of a program for the active management of labor.
    López-Zeno JA; Peaceman AM; Adashek JA; Socol ML
    N Engl J Med; 1992 Feb; 326(7):450-4. PubMed ID: 1732771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unintended clinical consequences of the implementation of a checklist-based, low-dose oxytocin protocol.
    Rohn AE; Bastek JA; Sammel MD; Wang E; Srinivas SK
    Am J Perinatol; 2015 Mar; 32(4):371-8. PubMed ID: 25217735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High- versus low-dose oxytocin for labor stimulation.
    Satin AJ; Leveno KJ; Sherman ML; Brewster DS; Cunningham FG
    Obstet Gynecol; 1992 Jul; 80(1):111-6. PubMed ID: 1603479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primiparas with or without oxytocin augmentation: a prospective descriptive study.
    Svärdby K; Nordström L; Sellström E
    J Clin Nurs; 2007 Jan; 16(1):179-84. PubMed ID: 17181680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternity Care Update: Labor and Delivery.
    Smith A; Barr WB; Bassett-Novoa E; LeFevre N
    FP Essent; 2018 Apr; 467():25-32. PubMed ID: 29683307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obstetric outcomes in oxytocin-related and spontaneous deliveries--analysis of 2198 cases].
    Raba G; Baran P
    Ginekol Pol; 2009 Jul; 80(7):508-11. PubMed ID: 19697814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns.
    Garite TJ; Dildy GA; McNamara H; Nageotte MP; Boehm FH; Dellinger EH; Knuppel RA; Porreco RP; Miller HS; Sunderji S; Varner MW; Swedlow DB
    Am J Obstet Gynecol; 2000 Nov; 183(5):1049-58. PubMed ID: 11084540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and abuse of oxytocin for augmentation of labor.
    Selin L; Almström E; Wallin G; Berg M
    Acta Obstet Gynecol Scand; 2009; 88(12):1352-7. PubMed ID: 19878049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E vaginal gel to treat dystocia in spontaneous labour: a multicentre randomised placebo-controlled trial.
    Oppenheimer LW; Labrecque M; Wells G; Bland ES; Fraser WD; Eason E; Brisson-Carroll G; Yetisir E
    BJOG; 2005 May; 112(5):612-8. PubMed ID: 15842286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with an active labour management protocol and reduction of caesarean section rate in Nicaragua.
    Bood T
    Trop Doct; 1990 Jul; 20(3):115-8. PubMed ID: 2219421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine contraction pattern as a predictor of the mode of delivery.
    Oppenheimer LW; Bland ES; Dabrowski A; Holmes P; McDonald O; Wen SW
    J Perinatol; 2002 Mar; 22(2):149-53. PubMed ID: 11896521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal and neonatal outcomes after oxytocin augmentation in patients undergoing a trial of labor after prior cesarean delivery.
    Chelmow D; Laros RK
    Obstet Gynecol; 1992 Dec; 80(6):966-71. PubMed ID: 1448265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In case of fetal macrosomia, the best strategy is the induction of labor at 38 weeks of gestation].
    Rozenberg P
    J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):1037-1044. PubMed ID: 27771202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chorioamnionitis: a harbinger of dystocia.
    Satin AJ; Maberry MC; Leveno KJ; Sherman ML; Kline DM
    Obstet Gynecol; 1992 Jun; 79(6):913-5. PubMed ID: 1579312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.